CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Chief Financial Officer bought 5,263 shares at $19.00 ($99,997)
- 4 Open-market buy Director bought 5,030 shares at $19.00 ($95,570)
- 4 Conversion Director acquired 152,446 shares (conversion)
- 4 Conversion Director acquired 489,542 shares (conversion)
- 4 Open-market buy Director bought 1,315 shares at $19.00 ($24,985)
- 4 Conversion Director acquired 4,203,757 shares (conversion)
- 4 Conversion Director acquired 711,447 shares (conversion)
- 8-K Event Executive or director change · Bylaws or fiscal year change
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 26 of 28 · 548 filings